Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
20 DMA Support | Bullish | -4.78% | |
Wide Bands | Range Expansion | -4.78% | |
MACD Bearish Signal Line Cross | Bearish | -2.69% | |
Wide Bands | Range Expansion | -2.69% | |
Wide Bands | Range Expansion | -8.51% | |
Wide Bands | Range Expansion | -3.40% | |
200 DMA Resistance | Bearish | -7.01% | |
Inside Day | Range Contraction | -7.01% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 16 hours ago |
Fell Below Previous Day's Low | about 16 hours ago |
Down 3% | about 16 hours ago |
Down 2 % | about 16 hours ago |
Fell Below 20 DMA | about 16 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/25/2024
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Amyloid Amyloidosis Neurodegeneration Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.3099 |
52 Week Low | 1.8101 |
Average Volume | 370,820 |
200-Day Moving Average | 4.42 |
50-Day Moving Average | 3.70 |
20-Day Moving Average | 4.07 |
10-Day Moving Average | 4.25 |
Average True Range | 0.26 |
RSI (14) | 50.74 |
ADX | 35.24 |
+DI | 24.45 |
-DI | 15.34 |
Chandelier Exit (Long, 3 ATRs) | 4.30 |
Chandelier Exit (Short, 3 ATRs) | 3.87 |
Upper Bollinger Bands | 4.87 |
Lower Bollinger Band | 3.28 |
Percent B (%b) | 0.44 |
BandWidth | 39.11 |
MACD Line | 0.18 |
MACD Signal Line | 0.23 |
MACD Histogram | -0.0439 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.36 | ||||
Resistance 3 (R3) | 4.40 | 4.32 | 4.30 | ||
Resistance 2 (R2) | 4.32 | 4.22 | 4.30 | 4.28 | |
Resistance 1 (R1) | 4.15 | 4.16 | 4.11 | 4.11 | 4.26 |
Pivot Point | 4.06 | 4.06 | 4.04 | 4.04 | 4.06 |
Support 1 (S1) | 3.89 | 3.96 | 3.85 | 3.85 | 3.70 |
Support 2 (S2) | 3.81 | 3.90 | 3.79 | 3.68 | |
Support 3 (S3) | 3.64 | 3.81 | 3.66 | ||
Support 4 (S4) | 3.60 |